AgomAb Therapeutics Ownership & Insider Activity

AgomAb Therapeutics (AGMB) institutional and insider ownership, recent insider transactions and ownership breakdown.

Institutional investors hold 13.6%. Over the past 90 days, insiders made 5 purchases worth $400K.

Shares Outstanding

49.248M

Shares Float

40.755M

Institutional Shares Held

6.715M

Institutional % Held

13.6%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

$400K total

Sales (90d)

Net Activity

Net Buying

Net Value (90d)

$400K

AgomAb Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Oct 21, 2026	David Epstein	DIRECTOR	BUY	10.000K	$8.88	$89K
Oct 8, 2026	David Epstein	DIRECTOR	BUY	5.000K	$8.90	$45K
Oct 6, 2026	Victor Thadee Pierre Kemula	CHIEF FINANCIAL OFFICER	BUY	10.000K	$8.59	$86K
Oct 5, 2026	David Epstein	DIRECTOR	BUY	10.000K	$8.63	$86K
Oct 5, 2026	Jasper Tim Knotnerus	CHIEF EXECUTIVE OFFICER	BUY	11.000K	$8.58	$94K